A bill has been introduced to Australia's Federal Parliament that could see a legal home grow and commercial cannabis market launch across the nation...

A recent poll indicates 44% of Americans are less likely to use cannabidiol products after learning the FDA is yet to implement consumer protection...

Australia's Bioxyne Limited (ASX: BXN) has announced its subsidiary, Breathe Life Sciences (BLS), has manufactured and delivered Australia’s first pharmaceutical-grade cannabis pastilles - also...

Researchers from University of Sydney's Lambert Initiative for Cannabinoid Therapeutics have launched a new Cannabis as Medicine survey (CAMS22) this week.The Cannabis as Medicine...